Just launched - feedback most welcome!
Send feedback

COVID-19 Evidence Alerts
from McMaster PLUSTM

Current best evidence for clinical care (more info)

Back to homepage

Prognosis Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea. Osong Public Health Res Perspect. 2020 Apr;11(2):85-90. doi: 10.24171/j.phrp.2020.11.2.05.
Abstract

We report the first 7,755 patients with confirmed COVID-19 in Korea as of March 12th, 2020. A total of 66 deaths have been recorded, giving a case fatality proportion of 0.9%. Older people, and those with comorbidities were at a higher risk of a fatal outcome. The highest number of cases of COVID-19 were in Daegu, followed by Gyeongbuk. This summary may help to understand the disease dynamics in the early phase of the COVID-19 outbreaks, and may therefore, guide future public health measures.

Ratings
Discipline / Specialty Area Score
Public Health
Hospital Doctor/Hospitalists
Internal Medicine
Family Medicine (FM)/General Practice (GP)
General Internal Medicine-Primary Care(US)
Intensivist/Critical Care
Pediatric Neonatology
Pediatric Hospital Medicine
Infectious Disease
Comments from MORE raters

Family Medicine (FM)/General Practice (GP) rater

I am unsure of the relevance of this for primary care at this point in the pandemic.

Infectious Disease rater

It only provides epidemiological data, without clinical or other data. It also does not represent a relevant change in what we know.

Intensivist/Critical Care rater

This provides information similar to that available in other countries. I’m not sure of its relevance to front line providers.

Intensivist/Critical Care rater

Less than a quarter of patients were 60-year or older, which could explain low mortality rate reported.

Intensivist/Critical Care rater

This is a a case series, with usual limitations, but it's a very interesting description of the epidemiology of the epidemic in one of the early hit country.

Pediatric Hospital Medicine rater

Given the need to compare approaches to containment of pandemic viruses for the future, this article is important as one of many bricks in the structure to configure an evidence based approach. It will be important to compare this data in light of Scandinavian and other European approaches to case identification, tracking, and treatment and the question of whether to and the details of how to implement social distancing.